Standout Papers

Purified multiplication‐stimulating activity from rat liver cell conditioned medium: Compari... 1974 2026 1991 2008 101
  1. Purified multiplication‐stimulating activity from rat liver cell conditioned medium: Comparison of biological activities with calf serum, insulin, and somatomedin (1974)
    G. Smith, Howard M. Temin Journal of Cellular Physiology

Citation Impact

Citing Papers

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
An Alkaline Earth I3O0 Porous Coordination Polymer: [Ba2TMA(NO3)(DMF)]
2012 StandoutNobel
Secondary building units, nets and bonding in the chemistry of metal–organic frameworks
2009 StandoutNobel
Nomograms in oncology: more than meets the eye
2015 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
1993
Increased Activity of Insulin-Like Growth Factor (IGF) in Osteoblastic Cells in the Presence of Growth Hormone (GH): Positive Correlation with the Presence of the GHInduced IGF-Binding Protein BP-3
1990
Uterine Insulin-Like Growth Factor-1: Regulation of Expression and Its Role in Estrogen-Induced Uterine Proliferation*
1990
Antithrombotic Therapy for VTE Disease
2012 Standout
Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein
1988 StandoutNatureNobel
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase
2001 StandoutNobel
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
2008 StandoutNature
“Heterogeneity within Order” in Metal–Organic Frameworks
2015 StandoutNobel
Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer Cells
1996
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
1994 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Great expectations: can artificial molecular machines deliver on their promise?
2011 StandoutNobel
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Mutations in GNA11 in Uveal Melanoma
2010 Standout
A GPT‐4 Reticular Chemist for Guiding MOF Discovery**
2023 StandoutNobel
Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.
1993 StandoutNobel
Topological Analysis of Metal–Organic Frameworks with Polytopic Linkers and/or Multiple Building Units and the Minimal Transitivity Principle
2013 StandoutNobel
Reset of the pre-replicative phase of human glia cells in culture
1977
Junctional intercellular communication and the control of growth
1979 Standout
Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence.
1988 StandoutNobel
A Multiunit Catalyst with Synergistic Stability and Reactivity: A Polyoxometalate–Metal Organic Framework for Aerobic Decontamination
2011 StandoutNobel
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
1999 StandoutScience
Aromatizing Olefin Metathesis by Ligand Isolation inside a Metal– Organic Framework
2013 StandoutNobel
Biological and Molecular Studies of the Mitogenic Effects of Human Epidermal Growth Factor
1978 StandoutNobel
Characterization of the binding of multiplication-stimulating activity to a receptor for growth polypeptides in chick embryo fibroblasts.
1977
Sustained release of epidermal growth factor accelerates wound repair.
1985
Identification of two anti-parallel beta-sheet conformations in the solution structure of murine epidermal growth factor by proton magnetic resonance.
1986 StandoutNobel
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
1983 Standout
Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells
1976 StandoutNatureNobel
Regulation of transmembrane signaling by receptor phosphorylation
1987 StandoutNobel
Proposed mechanism of insulin-resistant glucose transport in the isolated guinea pig adipocyte. Small intracellular pool of glucose transporters.
1983 StandoutNobel
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.
1976 StandoutNobel
Metal–Organic Framework Materials as Chemical Sensors
2011 Standout
Tyrosine phosphorylation of specific proteins after mitogen stimulation of chicken embryo fibroblasts.
1983
Human epidermal growth factor and the proliferation of human fibroblasts
1976 StandoutNobel
A line of non‐tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth
1987
Dual control of cell growth by somatomedins and platelet-derived growth factor.
1979
Hormonal Control of Immunoreactive Somatomedin Production by Cultured Human Fibroblasts
1981
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
1982
Characterization of insulin-like growth factor I-stimulated tyrosine kinase activity associated with the beta-subunit of type I insulin-like growth factor receptors of rat liver cells.
1985
Purification of the major protein-tyrosine-phosphatases of human placenta.
1988 StandoutNobel
Biochemical properties of the endothelium‐derived growth factor: Comparision to other growth factors
1983
Fluorescent Sensors for Zn2+Based on a Fluorescein Platform:  Synthesis, Properties and Intracellular Distribution
2001 StandoutNobel
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.
1978 StandoutNobel
Okadaic acid mimics the action of insulin in stimulating protein kinase activity in isolated adipocytes. The role of protein phosphatase 2a in attenuation of the signal.
1990 StandoutNobel
Subdivision of the G1 phase of human glia cells in culture
1976
Deconstructing the Crystal Structures of Metal–Organic Frameworks and Related Materials into Their Underlying Nets
2011 StandoutNobel
Role of cell shape in growth control
1978 StandoutNature
Synthesis of Metal-Organic Frameworks (MOFs): Routes to Various MOF Topologies, Morphologies, and Composites
2011 Standout
Epidermal Growth Factor
1979 StandoutNobel
A New Cell-Permeable Fluorescent Probe for Zn2+
2000 StandoutNobel
Engineering Metal Organic Frameworks for Heterogeneous Catalysis
2010 Standout
Plasma binding proteins for platelet-derived growth factor that inhibit its binding to cell-surface receptors.
1984
Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry.
1987 StandoutNobel
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
1984 StandoutNature
Absorption of CO2 and CS2 into the Hofmann-Type Porous Coordination Polymer: Electrostatic versus Dispersion Interactions
2013 StandoutNobel
The biology of platelet-derived growth factor
1986 Standout
Control of growth of mammalian cells in cell culture
1975 Nature
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
A Metal−Organic Framework with Covalently Bound Organometallic Complexes
2010 StandoutNobel
A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain
1987
Homochiral Metal–Organic Frameworks for Asymmetric Heterogeneous Catalysis
2011 Standout

Works of G. Smith being referenced

Endovenous therapy for deep venous thrombosis: The TORPEDO trial
2010
Silver(I) Phenoxyalkanoates: The Crystal and Molecular-Structures of catena -[Bis-μ-(phenoxyacetato-O,O')-disilver(I)] and Bis[bis-μ-(4-fluoro-phenoxyacetato-O,O')-bis{aquasilver(I)}]
1990
Regulation of amino acid transport in chicken embryo fibroblasts by purified multiplication‐stimulating activity (MSA)
1980
Nomogram to Predict Cycle-One Serious Drug-Related Toxicity in Phase I Oncology Trials
2014
Purified multiplication‐stimulating activity from rat liver cell conditioned medium: Comparison of biological activities with calf serum, insulin, and somatomedin
1974 StandoutNobel
A method for culturing chick melanocytes: The effect of BRL-3A cell conditioning and related additives
1982
Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein.
1980
A FLUORESCENT METHOD FOR THE DETECTION AND LOCALIZATION OF ZINC IN HUMAN GRANULOCYTES
1969
Rankless by CCL
2026